Skip to the page

Data / Form D filings / LadeRx, LLC

LadeRx, LLC: Form D filings

LadeRx, LLC, a pharmaceuticals company in Durham, NC, filed 2 Form D notices with the SEC between 2023 and 2026. The latest, on April 29, 2026, reports an offering of $3 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3225 SURREY ROAD, Durham, NC, 27707
Phone
(919) 949-4144
Industry
Pharmaceuticals
Entity type
Limited Liability Company
Incorporated in
North Carolina
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1970543

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 29, 2026New notice$3,000,000$0$3,000,0000Yet to occursec.gov
Mar 27, 2023New notice$2,000,000$66,669$1,933,33111Mar 3, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Lanty L. SmithExecutive Officer
Margaret E. SmithExecutive Officer
Joseph K. McCaffreyExecutive Officer
Banks Jefferson ClarkExecutive Officer
Christopher LascolaExecutive Officer

Other pharmaceuticals companies in North Carolina that filed recently

Every Form D from the week of Apr 27, 2026 · All recent filings in North Carolina · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what LadeRx, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.